ZA984100B - Process for the detection of HIV antibodies and antigens used in it. - Google Patents

Process for the detection of HIV antibodies and antigens used in it.

Info

Publication number
ZA984100B
ZA984100B ZA9804100A ZA984100A ZA984100B ZA 984100 B ZA984100 B ZA 984100B ZA 9804100 A ZA9804100 A ZA 9804100A ZA 984100 A ZA984100 A ZA 984100A ZA 984100 B ZA984100 B ZA 984100B
Authority
ZA
South Africa
Prior art keywords
detection
hiv antibodies
antigens used
antigens
hiv
Prior art date
Application number
ZA9804100A
Other languages
English (en)
Inventor
Frederic Donie
Elke Faatz
Eva Hoess
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of ZA984100B publication Critical patent/ZA984100B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA9804100A 1997-05-16 1998-05-15 Process for the detection of HIV antibodies and antigens used in it. ZA984100B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19720914A DE19720914A1 (de) 1997-05-16 1997-05-16 Verfahren zum Nachweis von HIV-Antikörpern und dazu verwendete Antigene

Publications (1)

Publication Number Publication Date
ZA984100B true ZA984100B (en) 1999-11-15

Family

ID=7829888

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9804100A ZA984100B (en) 1997-05-16 1998-05-15 Process for the detection of HIV antibodies and antigens used in it.

Country Status (10)

Country Link
US (1) US20030054336A1 (xx)
EP (1) EP0981543A1 (xx)
JP (1) JP2002511853A (xx)
CN (1) CN1263536A (xx)
AR (1) AR015659A1 (xx)
AU (1) AU8016998A (xx)
CA (1) CA2289679A1 (xx)
DE (1) DE19720914A1 (xx)
WO (1) WO1998052969A1 (xx)
ZA (1) ZA984100B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
DK3037429T3 (en) * 2006-07-28 2019-01-21 Univ Pennsylvania IMPROVED HIV VACCINES
AU2007283186A1 (en) * 2006-08-08 2008-02-14 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Improved immunoassay involving mutant antigens to reduce unspecific binding
FR2987836A1 (fr) * 2012-03-09 2013-09-13 Biomerieux Sa Peptides d'interference et procede de detection de microorganismes
CN108997482A (zh) * 2018-08-09 2018-12-14 东莞市朋志生物科技有限公司 用于检测hiv-1的合成肽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006005A1 (en) * 1986-03-24 1987-10-08 Ortho Pharmaceutical Corporation Synthetic htlv-iii peptides, compositions and uses thereof
AU641375B2 (en) * 1988-12-20 1993-09-23 Clarity Technologies Incorporated Synthetic HIV-like peptides, their compositions and uses
IE901427A1 (en) * 1990-07-23 1991-11-06 Prendergast Patrick T Treatment for viral interference
FR2730493B1 (fr) * 1995-02-09 1997-04-18 Pasteur Institut Polypeptides de glycoproteine transmembranaire d'enveloppe du retrovirus humain du type hiv-1 et polypeptides presentant avec eux une parente immunologique

Also Published As

Publication number Publication date
EP0981543A1 (de) 2000-03-01
US20030054336A1 (en) 2003-03-20
WO1998052969A1 (de) 1998-11-26
JP2002511853A (ja) 2002-04-16
AR015659A1 (es) 2001-05-16
AU8016998A (en) 1998-12-11
CA2289679A1 (en) 1998-11-26
CN1263536A (zh) 2000-08-16
DE19720914A1 (de) 1998-11-19

Similar Documents

Publication Publication Date Title
ZA987540B (en) Process for the preparation of stanol esters, and use thereof.
EP0842948A4 (en) ANTIBODIES OF LIGAND ANTIFas AND METHOD OF TESTING USING SAME
EP0638805A3 (en) Device and method for detecting an analyte.
EP0970966A4 (en) FUNGAL ANTIGENS AND PROCESSES OF MANUFACTURE
EP0701696A4 (en) ANTIGENS OF THE BLUST STADIUM OF PLSAMODIUM VIVAX, ANTIBODIES AND DIAGNOSTIC TESTS
TR199700352A3 (tr) Miknatislanmaz ürünlerde manyetik maddelerin tespiti için yöntem ve cihaz.
EP0670294A3 (en) Process for the production of hexafluoropropane and perfluoropropane.
EP0805161A4 (en) PROTEIN BINDING (1-3) -BETA-D-GLUCANE, PROTEIN RECOGNIZING ANTIBODIES AND USE OF PROTEIN AND ANTIBODY
ZA976967B (en) Device and process for separating magnetic materials from pharmaceutical preparations, their starting or intermediate products, as well as agents that are produced with the of said device.
IL109445A0 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
AU6220096A (en) Method for the simultaneous detection of different antibodies and/or antigens
GB2307041B (en) Sheets,kits and methods for detecting antigens or antibodies
IL98769A0 (en) Synthetic peptides,mixtures thereof and methods utilizing the same for detecting hiv antibodies
HUP9904222A3 (en) Assay for the detection of antibodies against p53
ZA984100B (en) Process for the detection of HIV antibodies and antigens used in it.
AU2696495A (en) Method for determining hiv-1 antigen and antibody
EP0759943A4 (en) MONOCLONAL ANTIBODIES SPECIFIC TO AN ENDOGLYX-1 ANTIGEN OF VASCULAR ENDOTHELIAL CELLS, THE ANTIGEN ITSELF AND USES THEREOF
EP0714510A4 (en) SPECIFIC ANTIGEN FOR NATURAL KILLING CELLS AND ANTIBODIES FOR IDENTIFYING THIS ANTIGEN
GB9710875D0 (en) Assay for detecting HIV antigens and HIV antibodies
AU9052491A (en) Assay device and method for antibody and antigen detection
GB2293009B (en) Sheets, kits and methods for detecting antigens or antibodies
EP1080102A4 (en) ANTIGENE AND YOUR DETECTION
EP0608117A3 (en) Antibodies for mevalonic acid and methods for determination of mevalonic acid.
GB9713666D0 (en) Biosensor materials and methods
GB9804529D0 (en) Method for the detection of antigens or antibodies